Proprietary analytical methodologies, bioactivity screening, and end-to-end translational pipelines from our certified Chinese manufacturing base.
De-risking the botanical development lifecycle through end-to-end analytical rigor, verified biostatistics, and industrialized batch reproducibility.
The modern CDMO model is transforming from simple capacity rental to integrated scientific partnership. Life science innovators no longer sustain expensive in-house botanical chemistry laboratories, turning instead to specialized contract development and manufacturing organizations with validated analytical infrastructure.
Stringent pharmacopeial requirements (USP, Ph. Eur., ChP) demand strict quantification of active secondary metabolites. CDMOs must substantiate botanical raw materials through multi-wavelength HPLC, GC-MS, and high-performance thin-layer chromatography (HPTLC) fingerprinting to eliminate adulteration and pesticide residues.
Global brands rely on quantified clinical endpoints to protect pricing integrity. Contract manufacturers must deliver more than raw bulk extract; they must produce preclinical toxicology packages, cell-based bioassays, and human clinical validation datasets ready for multi-market dossier filing.
Strategically leveraging localized raw material access, integrated supply chains, and technical engineering talent to accelerate lead times.
With direct access to diverse botanical production belts across mainland China, extraction facilities eliminate international transport degradation. We evaluate plant potency variations across micro-climates, soil compositions, and harvest calendars to procure maximum active density.
Our facility operates an unbroken technical continuum from 50L pilot development extraction to 10-ton industrial batch processing. Process parameters such as solvent recirculation, vacuum concentration, and spray drying map directly without engineering yield drop-offs.
Operating strictly under cGMP conditions, every research parameter, isolated fraction ratio, and formulation process is protected by non-disclosure legal infrastructure. Full batch traceability provides an auditable paper trail from agricultural field to delivery port.
Translating complex botanical secondary metabolites into diverse, bioavailable, and shelf-stable market formulations.
We engineer high-density botanical active ingredients optimized for cold-water solubility, neutral sensory attributes, and gastrointestinal absorption. Ideal for dietary supplements, functional beverages, and clinical dietary powders requiring verified label claims.
Providing full IND and NDA documentation packages for regulated botanical therapeutics. Our technical pipeline encompasses molecular active ingredient screening, LD50 safety quantification, animal efficacy models, and multi-center Phase I–IV clinical study design.
Formulating standardized polyphenol, flavonoid, and triterpenoid extracts with documented anti-inflammatory, tyrosinase inhibition, and barrier-repair capabilities. Backed by human patch safety data and in vitro cellular antioxidant assays.
Navigating clean-label mandates, automated supply chains, and quantitative analytical compliance for multinational purchasers.
Buyers are moving away from non-specific UV spectrophotometric assays. Leading international pharmaceutical manufacturers demand multi-marker chromatographic fingerprinting to verify botanical identity and eliminate economic adulteration across seasons.
Consumer pressure for clean-label botanical ingredients has accelerated the obsolescence of toxic petroleum-based solvents. Strategic procurement directs capital toward CDMOs utilizing supercritical CO2, water-ethanol closed loops, and membrane filtration separation.
To counter maritime disruptions, multinational brands require contractual vendor inventory buffering. Partnering with a vertically integrated manufacturer capable of carrying bonded raw material reservoirs guarantees lead-time integrity.
Our validated methodologies power commercial formulations across premier academic healthcare institutions and pharmaceutical conglomerates.
Clear answers to streamline sourcing decisions for procurement teams, clinical scientists, and brand architects.
Select individual analytical testing packages or integrate full commercial turnkey contract manufacturing solutions.
